摘要
目的：研究利培酮口服液与度洛西汀联合方案治疗慢性精神分裂症阴性症状的临床效果。方法选取2011年10月-2014年6月于本院进行治疗的72例以阴性症状为主的慢性精神分裂症患者分为对照组（单纯采用利培酮口服液治疗）和观察组（采用利培酮口服液与度洛西汀联合方案治疗）各36例，对比观察两组患者治疗的临床效果。结果观察组患者治疗的总有效率（86.11%）显著优于对照组（58.33%）， P＜0.05，差异具有统计学意义。结论利培酮口服液与度洛西汀联合方案治疗慢性精神分裂症阴性症状的临床效果较好，值得临床推广应用。
Objective Tostudy the clinical effect of risperidone oral solution combined with duloxetine for the treatment for negative symptoms of chronic schizophrenia. Methods From October, 2011 to June 2014, 72 patients with negative symptoms of chronic schizophrenia were divided into control group, simple risperidone oral solution group, n=36, and observation group, risperidone oral solution combined with duloxetine group, n=36, in our hospital. The curative effect was observed and compared. Results The total effective rate of observation group was （86.11%）. It was significantly better than the control group （58.33%）, P〈0.05, there was statistical signiifcance. Conclusions The clinical effect of risperidone oral solution combined with duloxetine for the treatment for negative symptoms of chronic schizophrenia was better. It was worthy of clinical promotion.
出处
《中国继续医学教育》
2015年第2期150-151,共2页
China Continuing Medical Education
关键词
利培酮口服液
度洛西汀
联合方案
慢性精神分裂症
阴性症状
Risperidone oral solution
Duloxetine
Joint programs
Chronic schizophrenia
Negative symptoms
